Nagata Y - Search Results

1

Intraductal papillary mucinous neoplasm in an annular pancreas: a case report.

Kobayashi S, Kamohara Y, Nagata Y, Ito M, Fujioka H. Kobayashi S, et al. Among authors: nagata y. Surg Case Rep. 2015 Dec;1(1):68. doi: 10.1186/s40792-015-0068-7. Epub 2015 Aug 25. Surg Case Rep. 2015. PMID: 26943411 Free PMC article.

2

Effects of intermittent 5-fluorouracil and low-dose cisplatin therapy on advanced and recurrent gastric cancer.

Kanetaka K, Enjoji A, Furui J, Nagata Y, Fujioka H, Shiogama T, Miyata A, Kishikawa H, Matsuo S, Iwata T, Kanematsu T, Eguchi S; Nagasaki Study Group for Digestive Organ Cancer Chemotherapy. Kanetaka K, et al. Among authors: nagata y. Anticancer Res. 2012 Aug;32(8):3495-9. Anticancer Res. 2012. PMID: 22843936 Clinical Trial.

3

Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case.

Kobayashi S, Nagata Y, Tokai H, Ito M, Fujioka H. Kobayashi S, et al. Among authors: nagata y. Clin Case Rep. 2015 Aug;3(8):681-5. doi: 10.1002/ccr3.295. Epub 2015 Jun 18. Clin Case Rep. 2015. PMID: 26331012 Free PMC article.

4

Severe neutrophilic leukocytosis as a progression marker in granulocyte colony-stimulating factor-producing squamous cell carcinoma of the esophagus.

Yamaguchi S, Kanetaka K, Kobayashi S, Nagata Y, Kinosita N, Fukuoka J, Murakami S, Fujita F, Takatsuki M, Eguchi S. Yamaguchi S, et al. Among authors: nagata y. Clin Case Rep. 2017 Mar 31;5(5):688-693. doi: 10.1002/ccr3.908. eCollection 2017 May. Clin Case Rep. 2017. PMID: 28469877 Free PMC article.

5

The long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report.

Tokai H, Nagata Y, Taniguchi K, Matsumura N, Kitasato A, Tokunaga T, Takeshita H, Kuroki T, Maeda S, Ito M, Fujioka H. Tokai H, et al. Among authors: nagata y. Surg Case Rep. 2017 Nov 25;3(1):117. doi: 10.1186/s40792-017-0394-z. Surg Case Rep. 2017. PMID: 29177806 Free PMC article.

6

Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature.

Yoshimoto T, Kobayashi S, Kanetaka K, Kobayashi K, Nagata Y, Morita M, Isagawa Y, Kinoshita N, Takatsuki M, Eguchi S. Yoshimoto T, et al. Among authors: nagata y. Surg Case Rep. 2018 Feb 17;4(1):18. doi: 10.1186/s40792-018-0425-4. Surg Case Rep. 2018. PMID: 29455418 Free PMC article.

7

Predictive factors for major postoperative complications related to gastric conduit reconstruction in thoracoscopic esophagectomy for esophageal cancer: a case control study.

Kobayashi S, Kanetaka K, Nagata Y, Nakayama M, Matsumoto R, Takatsuki M, Eguchi S. Kobayashi S, et al. Among authors: nagata y. BMC Surg. 2018 Mar 6;18(1):15. doi: 10.1186/s12893-018-0348-9. BMC Surg. 2018. PMID: 29510754 Free PMC article.

8

Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment.

Hirayama T, Nagata Y, Nishida M, Matsuo M, Kobayashi S, Yoneda A, Kanetaka K, Udono H, Eguchi S. Hirayama T, et al. Among authors: nagata y. Anticancer Res. 2019 Sep;39(9):4699-4709. doi: 10.21873/anticanres.13652. Anticancer Res. 2019. PMID: 31519569

9

Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial.

Okumura S, Ishihara M, Kiyota N, Yakushijin K, Takada K, Kobayashi S, Ikeda H, Endo M, Kato K, Kitano S, Matsumine A, Nagata Y, Kageyama S, Shiraishi T, Yamada T, Horibe K, Takesako K, Miwa H, Watanabe T, Miyahara Y, Shiku H. Okumura S, et al. Among authors: nagata y. BMJ Open. 2022 Nov 14;12(11):e065109. doi: 10.1136/bmjopen-2022-065109. BMJ Open. 2022. PMID: 36375974 Free PMC article.

10

Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.

Nagata Y, Kageyama S, Ishikawa T, Kokura S, Okayama T, Abe T, Murakami M, Otsuka K, Ariyoshi T, Kojima T, Taniguchi K, Kobayashi S, Shimada H, Yajima S, Suzuki T, Hirano S, Tsuchikawa T, Shichinohe T, Ueda S, Kanetaka K, Yoneda A, Wada H, Doki Y, Yamaue H, Katsuda M, Ohi M, Yasuda H, Kondo K, Kataoka M, Kodera Y, Koike M, Shiraishi T, Miyahara Y, Goshima N, Fukuda E, Yamaguchi K, Sato E, Ikeda H, Yamada T, Osako M, Hirai K, Miyamoto H, Watanabe T, Shiku H. Nagata Y, et al. Cancer Immunol Immunother. 2022 Nov;71(11):2743-2755. doi: 10.1007/s00262-022-03194-5. Epub 2022 Apr 16. Cancer Immunol Immunother. 2022. PMID: 35429246 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,494 results

Search Page

Filters